Clinical trial begins to assess plasma efficacy to limit Covid-19: ICMR 0 07.05.2020 07:09 Business Standard Convalescent plasma is one of several emerging therapies. However, there is no robust evidence to support it for routine therapy Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
